Here are the DEF 14A proxy statements from Biodesix, Inc. (BDSX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow BDSX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BDSX filings page.
Biodesix, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on May 19, 2026 at 1:00 p.m. Mountain Time. Stockholders of record on March 23, 2026, when 10,107,219 common shares were outstanding, may vote online on four key proposals.
These proposals are the election of two Class III directors to serve until 2029, a non-binding advisory vote on 2025 compensation for named executive officers, an advisory vote on how often to hold future say‑on‑pay votes (the board recommends every one year), and ratification of KPMG LLP as independent auditor for 2026.
The proxy also outlines Biodesix’s board structure, committee membership, director and executive pay (including 2025 salary increases, cash bonuses and equity awards) and new severance and change‑in‑control agreements for senior executives, together with stock ownership, equity plan data and pay‑versus‑performance disclosures.